Crystal Structure of DH475 Fab in complex with Man9

N-acetyl-beta-D-glucosamine; 2-acetamido-2-deoxy-beta-D-glucose; 2-acetamido-2-deoxy-D-glucose; 2-acetamido-2-deoxy-glucose; N-ACETYL-D-GLUCOSAMINE

Analysis of two cooperating antibodies unveils immune pressure imposed on HIV Env to elicit a V3-glycan supersite broadly neutralizing antibody lineage.

EVQLLESGGGLVQPGGSLKLSCAASGFAVNNYPMNWVRQAPGKGLEWVSSIIGSGSRASYADSVKGRFTISRDNGKDIVY
LQMNNLRADDTALYYCVKDSSTAWWDKPAASEFDFWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFP
EPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDK

QLVLTQSPSASASLGASVKLTCTLNSGNTNFAVAWHQQQAGKGPRYLMTINSDGRQSRGDGIPDRFSGSTSGADRYLTIS
SLHFEDEGDYYCQAWTADLHVFGPGTRVAVVGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPV
KAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS

National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)

The reducing end NAG was altered to place an amine group on C1, which was then reacted with biotin. The electron density for the biotin, however, is not clear, and so the biotin is not modeled.

FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM, IMMUNE SYSTEM-ANTIGEN complex